UDIV:CA:TSX-Manulife Smart U.S. Dividend ETF Hedged (CAD)

ETF | Others |

Last Closing

CAD 13.87

Change

+0.18 (+1.31)%

Market Cap

CAD 0.10B

Volume

6.04K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-19 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

+0.45 (+1.58%)

CAD 6.19B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

+0.01 (+0.01%)

CAD 5.31B
PHYS-U:CA Sprott Physical Gold Trust

+0.29 (+1.46%)

CAD 4.76B
XEQT:CA iShares Core Equity Portfolio

+0.39 (+1.22%)

CAD 4.70B
XUS-U:CA iShares Core S&P 500 Index ETF

+0.60 (+1.69%)

CAD 4.54B
HXT-U:CA Horizons S&P/TSX 60 Index ETF

N/A

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

+0.59 (+2.50%)

CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

-0.04 (-0.38%)

CAD 3.29B
NSCB:CA NBI Sustainable Canadian Bond ..

-0.04 (-0.15%)

CAD 2.78B
ZMMK:CA BMO Money Market Fund ETF Seri..

+0.01 (+0.02%)

CAD 2.53B

ETFs Containing UDIV:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 12.31% 60% D- 55% F
Dividend Return 0.66% 49% F 20% F
Total Return 12.97% 59% D- 52% F
Trailing 12 Months  
Capital Gain 21.77% 69% C- 67% D+
Dividend Return 0.72% 47% F 15% F
Total Return 22.49% 68% D+ 62% D
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 1.60% 51% F 45% F
Dividend Return 1.77% 52% F 38% F
Total Return 0.17% 66% D+ 18% F
Risk Return Profile  
Volatility (Standard Deviation) 7.53% 54% F 78% C+
Risk Adjusted Return 23.51% 47% F 45% F
Market Capitalization 0.10B 63% D 35% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.